Structures by: Malatesti N.
Total: 6
(+)-(4<i>R</i>,5<i>S</i>)-4-Methyl-5-phenyl-3-[-2(<i>S</i>)-phenylpropionyl]- oxazolidin-2-one
C19H19NO3
Acta Crystallographica Section E (2006) 62, 9 o4032-o4034
a=14.757(2)Å b=6.069(2)Å c=9.109(4)Å
α=90.00° β=104.02(6)° γ=90.00°
(-)-(4<i>R</i>,5<i>S</i>)-4-Methyl-3-[2(<i>R</i>)-(4-methylphenyl)propionyl]- 5-phenyloxazolidin-2-one
C20H21NO3
Acta Crystallographica Section E (2006) 62, 9 o4037-o4038
a=13.066(8)Å b=9.509(8)Å c=7.201(4)Å
α=90.00° β=102.95(4)° γ=90.00°
(-)-(4<i>R</i>,5<i>S</i>)-3-[2(<i>R</i>)-(4-Chlorophenyl)propionyl]-4-methyl- 5-phenyloxazolidin-2-one
C19H18ClNO3
Acta Crystallographica Section E (2006) 62, 9 o4039-o4040
a=7.105(3)Å b=25.662(12)Å c=9.580(8)Å
α=90.00° β=90.00° γ=90.00°
(+)-(4<i>R</i>,5<i>S</i>)-4-Methyl-3-[2(<i>R</i>)-phenoxypropionyl]- 5-phenyloxazolidin-2-one
C19H19NO4
Acta Crystallographica Section E (2006) 62, 9 o4041-o4042
a=16.915(12)Å b=10.634(5)Å c=9.226(6)Å
α=90.00° β=90.00° γ=90.00°
(+)-(4<i>R</i>,5<i>S</i>)-3-[2(<i>S</i>)-(4-Isobutylphenyl)propionyl]- 4-methyl-5-phenyloxazolidin-2-one
C23H27NO3
Acta Crystallographica Section E (2006) 62, 9 o4035-o4036
a=7.194(4)Å b=14.208(8)Å c=20.049(11)Å
α=90.00° β=90.00° γ=90.00°
(-)-(4<i>R</i>,5<i>S</i>)-4-Methyl-3-[2(<i>S</i>)-phenoxypropionyl]- 5-phenyloxazolidin-2-one
C19H19NO4
Acta Crystallographica Section E (2006) 62, 9 o4043-o4045
a=11.268(7)Å b=10.493(5)Å c=15.008(9)Å
α=90.00° β=102.96(4)° γ=90.00°